CASC
Goldman Sachs’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-664,386
| Closed | -$2.46M | – | 4414 |
|
|
2017
Q4 | $2.46M | Buy |
664,386
+616,992
| +1,302% | +$2.28M | ﹤0.01% | 2721 |
|
|
2017
Q3 | $193K | Buy |
47,394
+27,268
| +135% | +$111K | ﹤0.01% | 3894 |
|
|
2017
Q2 | $75K | Sell |
20,126
-185,052
| -90% | -$690K | ﹤0.01% | 4197 |
|
|
2017
Q1 | $849K | Buy |
205,178
+185,081
| +921% | +$766K | ﹤0.01% | 3204 |
|
|
2016
Q4 | $87K | Sell |
20,097
-354,409
| -95% | -$1.53M | ﹤0.01% | 4129 |
|
|
2016
Q3 | $614K | Buy |
374,506
+70,135
| +23% | +$115K | ﹤0.01% | 3320 |
|
|
2016
Q2 | $287K | Buy |
304,371
+249,727
| +457% | +$235K | ﹤0.01% | 3647 |
|
|
2016
Q1 | $69K | Sell |
54,644
-19,184
| -26% | -$24.2K | ﹤0.01% | 4134 |
|
|
2015
Q4 | $164K | Buy |
73,828
+46,721
| +172% | +$104K | ﹤0.01% | 3820 |
|
|
2015
Q3 | $74K | Sell |
27,107
-49,417
| -65% | -$135K | ﹤0.01% | 4250 |
|
|
2015
Q2 | $286K | Buy |
76,524
+54,149
| +242% | +$202K | ﹤0.01% | 3748 |
|
|
2015
Q1 | $36K | Buy |
+22,375
| New | +$36K | ﹤0.01% | 4343 |
|
|
2014
Q4 | – | Sell |
-40,989
| Closed | -$79K | – | 4759 |
|
|
2014
Q3 | $79K | Buy |
40,989
+9,321
| +29% | +$18K | ﹤0.01% | 4287 |
|
|
2014
Q2 | $103K | Sell |
31,668
-4,547
| -13% | -$14.8K | ﹤0.01% | 4178 |
|
|
2014
Q1 | $109K | Buy |
36,215
+15,267
| +73% | +$46K | ﹤0.01% | 4127 |
|
|
2013
Q4 | $37K | Sell |
20,948
-233,871
| -92% | -$413K | ﹤0.01% | 4197 |
|
|
2013
Q3 | $525K | Sell |
254,819
-6,326
| -2% | -$13K | ﹤0.01% | 3310 |
|
|
2013
Q2 | $410K | Buy |
+261,145
| New | +$410K | ﹤0.01% | 3283 |
|